Table 2.
Correlations Between circ_0078607 Expression and Clinical Features in HGSOC Patients
| Parameter | Variable | circ-0078607 Expression | P value | |||
|---|---|---|---|---|---|---|
| Low | % | High | % | |||
| Age (years) | <60 | 14 | (28.57) | 10 | (20.41) | 0.483 |
| ≥60 | 17 | (34.69) | 8 | (16.33) | ||
| FIGO stage | I–II | 3 | (6.12) | 7 | (14.28) | 0.014 |
| III–IV | 28 | (57.14) | 11 | (22.45) | ||
| Tumor size (cm) | < 10 | 22 | (44.89) | 14 | (28.57) | 0.603 |
| ≥10 | 9 | (18.38) | 4 | (8.16) | ||
| Ascites (mL) | <1000 | 14 | (28.57) | 13 | (26.53) | 0.066 |
| ≥1000 | 17 | (34.70) | 5 | (10.20) | ||
| Serum CA125 (ng/mL) | <500 | 10 | (20.41) | 12 | (24.49) | 0.019 |
| ≥500 | 21 | (42.86) | 6 | (12.24) | ||
| Sensitivity to chemotherapy | Platinum sensitive | 20 | (40.82) | 15 | (30.61) | 0.159 |
| Platinum resistance | 11 | (22.45) | 3 | (6.12) | ||
| Vital status | Living | 8 | (16.33) | 10 | (20.4) | 0.037 |
| Deceased | 23 | (46.94) | 8 | (16.33) | ||